NOD2 exerted its anti-tumor effect through activation of AMPK pathway, and the latter is recognized to be involved in regulating the response to chemotherapy20–22; thus we were interested in defining whether NOD2 has any effect on the response of HCC cells to chemotherapy. Here, PRKAB1 is linked to hepatocellular carcinoma.